Reviewed Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2022 Reviewed Company Q2 30/06/2022 2022 Reviewed Consolidated Q2 30/06/2022 2022 Reviewed Company Q1 31/03
Revise 2022 Reviewed Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2022 Reviewed Company Q2 30/06/2022 2022 Reviewed Consolidated Q2 30/06/2022 2022 Reviewed
/2022 2022 Reviewed Consolidated Q3 30/09/2022 2022 Reviewed Company Q2 30/06/2022 2022 Reviewed Consolidated Q2 30/06/2022 2022 Reviewed Company Q1 31/03/2022 2022 Reviewed
) found) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2022 Reviewed
Period As Of Details WINNERGY MEDICAL PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 WINNERGY MEDICAL PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 WINNERGY MEDICAL PUBLIC
of consideration basis, calculated from the Company’s reviewed consolidated financial statements for 6-month period as of 30 June 2018. Therefore, the entering of transaction when combined with the
first quarter ended March 31, 2020 with those of 2019. This report discusses principal changes in the reviewed consolidated financial statements. Changes in Financial Reporting Standards The financial